ID

36883

Description

Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02342054

Lien

https://clinicaltrials.gov/show/NCT02342054

Mots-clés

Versions (1)
  1. 18/06/2019 18/06/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

18 juin 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Prostate Cancer NCT02342054

Anglais

Eligibility Prostate Cancer NCT02342054

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
men older than 18 years old
Description

Gender | Age

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
histologically confirmed diagnosis of adenocarcinoma of the prostate
Description

Adenocarcinoma of prostate

Type de données

boolean

Alias
UMLS CUI [1]
C0007112
clinical stage t1c/t2a disease
Description

Disease TNM clinical staging

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C3258246
low and intermediate risk disease defined as either gleason 6 or gleason 7 and psa < 20 ng/ml.
Description

Disease Low Risk | Disease Intermediate Risk | Gleason score | Prostate specific antigen measurement

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C3538919
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C3640764
UMLS CUI [3]
C3203027
UMLS CUI [4]
C0201544
prostate volume < 60 cc as determined by ultrasound, ct or mri
Description

Prostate volume Ultrasonography | Prostate volume CT | Prostate volume MRI

Type de données

boolean

Alias
UMLS CUI [1,1]
C1441416
UMLS CUI [1,2]
C0041618
UMLS CUI [2,1]
C1441416
UMLS CUI [2,2]
C0040405
UMLS CUI [3,1]
C1441416
UMLS CUI [3,2]
C0024485
life expectancy of more than 10 years
Description

Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
willing to give informed consent to participate in this clinical trial
Description

Informed Consent Willing

Type de données

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0600109
able and willing to complete expanded prostate index composite (epic) questionnaire
Description

Expanded Prostate Cancer Index Composite Completion

Type de données

boolean

Alias
UMLS CUI [1,1]
C3810535
UMLS CUI [1,2]
C0205197
eastern cooperative oncology group (ecog) of 0 - 2.
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
give competent informed consent to participate in this trial.
Description

Informed Consent Competent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0086035
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
documented nodal or distant metastases
Description

Secondary malignant neoplasm of lymph node | Distant metastasis

Type de données

boolean

Alias
UMLS CUI [1]
C0686619
UMLS CUI [2]
C1269798
previous pelvic radiotherapy
Description

Radiotherapy to pelvis

Type de données

boolean

Alias
UMLS CUI [1]
C1536155
previous trans-urethral resection of prostate, previous prostatectomy or hifu
Description

Transurethral Resection of Prostate | Prostatectomy | High-Intensity Focused Ultrasound Ablation

Type de données

boolean

Alias
UMLS CUI [1]
C0040771
UMLS CUI [2]
C0033573
UMLS CUI [3]
C2348970
use of androgen deprivation therapy. use of 5-alpha-reductase inhibitors is permitted
Description

Antiandrogen therapy | 5-alpha Reductase Inhibitors allowed

Type de données

boolean

Alias
UMLS CUI [1]
C0279492
UMLS CUI [2,1]
C2936788
UMLS CUI [2,2]
C0683607
poor baseline urinary function defined as international prostate symptom score (ipss) >19
Description

Urinary function Poor International Prostate Symptom Score

Type de données

boolean

Alias
UMLS CUI [1,1]
C0042034
UMLS CUI [1,2]
C0542537
UMLS CUI [1,3]
C1998280
contra-indication to radical prostate radiotherapy
Description

Medical contraindication Radiotherapy to prostate Radical

Type de données

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0948317
UMLS CUI [1,3]
C0439807
significant medical co-morbidity rendering patient unsuitable for general anaesthetic
Description

Comorbidity Significant | Patient Inappropriate General Anesthesia

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0750502
UMLS CUI [2,1]
C0030705
UMLS CUI [2,2]
C1548788
UMLS CUI [2,3]
C0002915
Retour au début de la page

Similar models

Eligibility Prostate Cancer NCT02342054

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
men older than 18 years old
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Adenocarcinoma of prostate
Item
histologically confirmed diagnosis of adenocarcinoma of the prostate
boolean
C0007112 (UMLS CUI [1])
Disease TNM clinical staging
Item
clinical stage t1c/t2a disease
boolean
C0012634 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Disease Low Risk | Disease Intermediate Risk | Gleason score | Prostate specific antigen measurement
Item
low and intermediate risk disease defined as either gleason 6 or gleason 7 and psa < 20 ng/ml.
boolean
C0012634 (UMLS CUI [1,1])
C3538919 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C3640764 (UMLS CUI [2,2])
C3203027 (UMLS CUI [3])
C0201544 (UMLS CUI [4])
Prostate volume Ultrasonography | Prostate volume CT | Prostate volume MRI
Item
prostate volume < 60 cc as determined by ultrasound, ct or mri
boolean
C1441416 (UMLS CUI [1,1])
C0041618 (UMLS CUI [1,2])
C1441416 (UMLS CUI [2,1])
C0040405 (UMLS CUI [2,2])
C1441416 (UMLS CUI [3,1])
C0024485 (UMLS CUI [3,2])
Life Expectancy
Item
life expectancy of more than 10 years
boolean
C0023671 (UMLS CUI [1])
Informed Consent Willing
Item
willing to give informed consent to participate in this clinical trial
boolean
C0021430 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
Expanded Prostate Cancer Index Composite Completion
Item
able and willing to complete expanded prostate index composite (epic) questionnaire
boolean
C3810535 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
ECOG performance status
Item
eastern cooperative oncology group (ecog) of 0 - 2.
boolean
C1520224 (UMLS CUI [1])
Informed Consent Competent
Item
give competent informed consent to participate in this trial.
boolean
C0021430 (UMLS CUI [1,1])
C0086035 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Secondary malignant neoplasm of lymph node | Distant metastasis
Item
documented nodal or distant metastases
boolean
C0686619 (UMLS CUI [1])
C1269798 (UMLS CUI [2])
Radiotherapy to pelvis
Item
previous pelvic radiotherapy
boolean
C1536155 (UMLS CUI [1])
Transurethral Resection of Prostate | Prostatectomy | High-Intensity Focused Ultrasound Ablation
Item
previous trans-urethral resection of prostate, previous prostatectomy or hifu
boolean
C0040771 (UMLS CUI [1])
C0033573 (UMLS CUI [2])
C2348970 (UMLS CUI [3])
Antiandrogen therapy | 5-alpha Reductase Inhibitors allowed
Item
use of androgen deprivation therapy. use of 5-alpha-reductase inhibitors is permitted
boolean
C0279492 (UMLS CUI [1])
C2936788 (UMLS CUI [2,1])
C0683607 (UMLS CUI [2,2])
Urinary function Poor International Prostate Symptom Score
Item
poor baseline urinary function defined as international prostate symptom score (ipss) >19
boolean
C0042034 (UMLS CUI [1,1])
C0542537 (UMLS CUI [1,2])
C1998280 (UMLS CUI [1,3])
Medical contraindication Radiotherapy to prostate Radical
Item
contra-indication to radical prostate radiotherapy
boolean
C1301624 (UMLS CUI [1,1])
C0948317 (UMLS CUI [1,2])
C0439807 (UMLS CUI [1,3])
Comorbidity Significant | Patient Inappropriate General Anesthesia
Item
significant medical co-morbidity rendering patient unsuitable for general anaesthetic
boolean
C0009488 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C0030705 (UMLS CUI [2,1])
C1548788 (UMLS CUI [2,2])
C0002915 (UMLS CUI [2,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial